Combinational effects of ponatinib and some Turkish endemic plant extracts on breast cancer cells

Çağla Kayabaşı, Ç. Avcı, Sunde Yilmaz Süslüer, Tuğçe Balcı Okcanoğlu, Besra ÖZMEN YELKEN, Cansu Caliskan Kurt, Bakiye Göker Bağca, C. Durmuskahya, H. Kayalar, A. Özbilgin, Cumhur Gündüz
{"title":"Combinational effects of ponatinib and some Turkish endemic plant extracts on breast cancer cells","authors":"Çağla Kayabaşı, Ç. Avcı, Sunde Yilmaz Süslüer, Tuğçe Balcı Okcanoğlu, Besra ÖZMEN YELKEN, Cansu Caliskan Kurt, Bakiye Göker Bağca, C. Durmuskahya, H. Kayalar, A. Özbilgin, Cumhur Gündüz","doi":"10.19161/etd.1126901","DOIUrl":null,"url":null,"abstract":"Aim: Breast cancer is the most common malignancy in women worldwide. Therefore, there is a need to define new strategies that can overcome the deficiencies of existing treatments. In our study, we aimed to define new herbal combination therapies that can be used to target breast cancer cells. For this purpose, we investigated the cytotoxic, apoptotic, anti-proliferative and cell cycle regulatory effects of Centaurea calolepis (CCI), Origanum sipyleum (OSM) and Phlomis lycia (PLI) plant extracts in combination with ponatinib on MCF-7 cells. \nMaterials and Methods: The cytotoxic effects of OSM, CCI, PLI and ponatinib on MCF-7 cells were measured in real time by xCELLigence. The median-effect equation was used for the analysis of combinations of ponatinib with CCI (p-CCI), OSM (p-OSM), PLI (p-PLI). Apoptosis, proliferation and cell cycle regulation were evaluated by flow cytometry. \nResults: The IC50 doses of CCI, OSM and PLI extracts in MCF-7 cells were calculated as 59.5, 57, 44.2 μg/ml at 48 hours and 51.6, 54.21, 42.52 μg/ml at 72 hours, respectively. Combination analyses revealed that p-CCI was additive, p-OSM and p-PLI showed a moderate synergistic effect at 48th hours. It was determined that apoptosis induced by ponatinib was significantly increased with the combinations of CCI and PLI. CCI and PLI treatments exhibited moderate anti-proliferative effects on MCF-7 cells, while OSM extract suppressed proliferation most significantly. Consistent with the proliferation results, the highest G0/G1 arrest was observed with OSM treatment. It was revealed that combined p-CCI and p-PLI treatments significantly increased the anti-proliferative effect of ponatinib and caused a higher level of G0/G1 accumulation. \nConclusion: Combinations of ponatinib and CCI, OSM, PLI plant extracts exhibited anti-cancer activity in breast cancer with induction of apoptosis, suppression of proliferation and cell cycle arrest. In light of the high anti-cancer effects identified, extracts of these Turkish endemic plants may represent a potential strategy in the treatment of breast cancer patients.","PeriodicalId":32499,"journal":{"name":"Ege Tip Dergisi","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ege Tip Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19161/etd.1126901","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Breast cancer is the most common malignancy in women worldwide. Therefore, there is a need to define new strategies that can overcome the deficiencies of existing treatments. In our study, we aimed to define new herbal combination therapies that can be used to target breast cancer cells. For this purpose, we investigated the cytotoxic, apoptotic, anti-proliferative and cell cycle regulatory effects of Centaurea calolepis (CCI), Origanum sipyleum (OSM) and Phlomis lycia (PLI) plant extracts in combination with ponatinib on MCF-7 cells. Materials and Methods: The cytotoxic effects of OSM, CCI, PLI and ponatinib on MCF-7 cells were measured in real time by xCELLigence. The median-effect equation was used for the analysis of combinations of ponatinib with CCI (p-CCI), OSM (p-OSM), PLI (p-PLI). Apoptosis, proliferation and cell cycle regulation were evaluated by flow cytometry. Results: The IC50 doses of CCI, OSM and PLI extracts in MCF-7 cells were calculated as 59.5, 57, 44.2 μg/ml at 48 hours and 51.6, 54.21, 42.52 μg/ml at 72 hours, respectively. Combination analyses revealed that p-CCI was additive, p-OSM and p-PLI showed a moderate synergistic effect at 48th hours. It was determined that apoptosis induced by ponatinib was significantly increased with the combinations of CCI and PLI. CCI and PLI treatments exhibited moderate anti-proliferative effects on MCF-7 cells, while OSM extract suppressed proliferation most significantly. Consistent with the proliferation results, the highest G0/G1 arrest was observed with OSM treatment. It was revealed that combined p-CCI and p-PLI treatments significantly increased the anti-proliferative effect of ponatinib and caused a higher level of G0/G1 accumulation. Conclusion: Combinations of ponatinib and CCI, OSM, PLI plant extracts exhibited anti-cancer activity in breast cancer with induction of apoptosis, suppression of proliferation and cell cycle arrest. In light of the high anti-cancer effects identified, extracts of these Turkish endemic plants may represent a potential strategy in the treatment of breast cancer patients.
波纳替尼与土耳其特有植物提取物对乳腺癌细胞的联合作用
目的:乳腺癌是世界范围内女性最常见的恶性肿瘤。因此,有必要确定新的策略,以克服现有治疗方法的不足。在我们的研究中,我们的目标是确定新的草药联合疗法,可用于靶向乳腺癌细胞。为此,我们研究了Centaurea calolepis (CCI)、Origanum sipyleum (OSM)和Phlomis lycia (PLI)植物提取物联合ponatinib对MCF-7细胞的细胞毒性、凋亡、抗增殖和细胞周期调控作用。材料与方法:采用xCELLigence实时检测OSM、CCI、PLI和ponatinib对MCF-7细胞的细胞毒作用。采用中效方程对泊纳替尼与CCI (p-CCI)、OSM (p-OSM)、PLI (p-PLI)联合用药进行分析。流式细胞术观察细胞凋亡、细胞增殖和细胞周期调节。结果:CCI、OSM、PLI提取物在MCF-7细胞48 h的IC50剂量分别为59.5、57、44.2 μg/ml, 72 h的IC50剂量分别为51.6、54.21、42.52 μg/ml。联合分析显示,p-CCI具有可加性,p-OSM和p-PLI在48h时表现出中等协同效应。结果表明,与CCI和PLI联合使用时,ponatinib诱导的细胞凋亡明显增加。CCI和PLI处理对MCF-7细胞的抑制作用中等,而OSM提取物对MCF-7细胞的抑制作用最显著。与增殖结果一致,OSM处理的G0/G1阻滞程度最高。结果显示,p-CCI和p-PLI联合治疗显著增强了ponatinib的抗增殖作用,使G0/G1积累水平升高。结论:ponatinib与CCI、OSM、PLI植物提取物联合应用具有诱导乳腺癌细胞凋亡、抑制细胞增殖、阻滞细胞周期的抗癌作用。鉴于已确定的高抗癌作用,这些土耳其特有植物的提取物可能代表治疗乳腺癌患者的潜在策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
79
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信